Answer
Yes, Spravato (esketamine hydrochloride) is contraindicated in patients with a history of intracerebral haemorrhage because an increase in blood pressure or intracranial pressure poses a serious risk.
Sources for this answer
- Spravato 28 mg nasal spray, solutionJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.3 Contraindications · Version 12Document updated
Sources checked